
|Articles|March 1, 2012
Summary and Closing of Discussion
Dr. Chernew summarizes key points of the discussion and asks members to add any additional information.
Advertisement
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Patients With CKD Are Less Likely to Receive Adjuvant Chemotherapy
2
FDA Approves Oral Semaglutide as First GLP-1 Pill for Weight Loss
3
Top 5 Most-Read Heart Failure Content of 2025
4
Overcoming Pain Points to Advance Bispecifics in the Community for Patients With Myeloma
5



































